Healthcare
The $TRILLION Opportunity in CRISPR & DNA Sequencing Technologies
Cathie Wood, of ARK Genomic Revolution ETF(NYSE: ARKG) explains the multi-trillion dollar opportunity in the Genomics Revolution: CAR-T, CRISPR, and DNA Sequencing
crispr